Eltrombopag for Adults and Children with Immune-Refractory Thrombocytopenic Purpura: A Systematic Review

Eltrombopag is an agonist that binds to the membrane-bound domain of the thrombopoietin receptor used in immune thrombocytopenic purpura (ITP). We conducted a meta-analysis of randomized controlled trials to assess the efficacy and safety of eltrombopag in adults and children with refractory ITP. Ad...

Descripción completa

Detalles Bibliográficos
Autores principales: de Barros Torelli, Danielle Francisco Honorato, Oliveira, Crystian Bitencourt Soares, Nai, Gisele Alborghetti, Trindade, Evelinda Marramon, Prestes-Carneiro, Luiz Euribel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299452/
https://www.ncbi.nlm.nih.gov/pubmed/37373566
http://dx.doi.org/10.3390/jcm12123872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299452/
https://www.ncbi.nlm.nih.gov/pubmed/37373566
http://dx.doi.org/10.3390/jcm12123872

Ejemplares similares